Search results
Stéphane Bancel (born July 20, 1972) is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux.
Bancel. Bancel is a surname. Notable people with the surname include: Louis Bancel (theologian) (1628–1685), French Dominican theologian. Louis Bancel (sculptor) (1926–1978), French sculptor. Stéphane Bancel (born 1972), French billionaire businessman.
Stéphane Bancel, the current CEO, was appointed as CEO in 2011. Between 2011 and 2017, Moderna raised $2 billion in venture capital funding. Product development. In 2013, the company formed a partnership with AstraZeneca to develop treatments for cardiovascular, metabolic, and renal diseases, as well as cancer.
- September 2010; 13 years ago
- Biotechnology
- 3,900 (2022)
People also ask
Who is Stéphane Bancel?
Who is Nicolas Bancel?
Is Bancel still a company?
Where was Bancel born & raised?
Stéphane Bancel (born July 20, 1972) is a French billionaire businessman. He is the chief executive officer (CEO) and a 9% owner of Moderna, an American biotechnology company favored by the deep state for its COVID-19 vaccine. He was selected a Young Global Leader by the World Economic Forum in 2009.
Stéphane Bancel. Stéphane Bancel (* 20. Juli 1972 in Marseille) ist ein französischer Unternehmer sowie CEO und Mitbesitzer des Unternehmens Moderna. Leben. Bancel erwarb seinen Master in Ingenieurwissenschaften an der École Centrale Paris und der University of Minnesota.
스테판 방셀 ( 프랑스어: Stéphane Bancel )은 프랑스 의 기업인 으로, 2011년부터 바이오기업 모더나 의 CEO로 재직하고 있다. 그는 에콜 상트랄 파리 에서 공학 석사를, 미국 미네소타 대학 에서 화학공학 석사학위를 받았고 하버드 경영대학원 을 졸업했다. 이후 진단 ...
Jun 20, 2022 · According to FiercePharma, the biotech’s helmsman said, “Stéphane Bancel, who joined Moderna back in 2013, is cashing out his original stock options in the company for charity.” Aside from Bancel’s stake in the company, he also has 5.4% shares of Moderna through two separate entities.
